Chinese journal of natural medicinesAnimalsDoxorubicinSaponinsIsoflavonesRats
The novel combination of astragaloside IV and formononetin protects from doxorubicin-induced cardiomyopathy by enhancing fatty acid metabolism.
Xinyue Yu, Zhaodi Han, Linling Guo, Shaoqian Deng, Jing Wu, Qingqing Pan, Liuyi Zhong, Jie Zhao, Hui Hui, Fengguo Xu, Zunjian Zhang, Yin Huang
Published: 202510.1016/S1875-5364(25)60868-5
Abstract
Astragali Radix (AR), a traditional Chinese medicine (TCM), has demonstrated therapeutic efficacy against various diseases, including cardiovascular conditions, over centuries of use. While doxorubicin serves as an effective chemotherapeutic agent ag…
Preview only. Read the full abstract at the source